August 28, 2014 11:17 AM ET

Pharmaceuticals

Company Overview of Euthymics Bioscience, Inc.

Company Overview

Euthymics Bioscience, Inc., a neuroscience-focused clinical stage biopharmaceutical company, is engaged in developing a novel medicine for major depressive disorders and alcohol use disorders. The company offers amitifadine, a serotonin-preferring triple reuptake inhibitor that acts on serotonin, norepinephrine, and dopamine in a specific ratio for treating major depressive disorders. Euthymics Bioscience, Inc. was founded in 2009 and is based in Cambridge, Massachusetts.

43 Thorndike Street

Suite S1-3

Cambridge, MA 02141

United States

Founded in 2009

Phone:

617-758-0300

Fax:

617-758-0420

Key Executives for Euthymics Bioscience, Inc.

Co-Founder
Age: 52
Co-founder and Chief Scientific Officer
Age: 69
Vice President of Finance & Administration
Chief Operating Officer
Age: 65
Chief Medical Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
ZARS Pharma, Inc. United States
ChiRhoClin, Inc. United States
Madeira Therapeutics LLC United States
Centrix Pharmaceutical, Inc. United States
Giantceutical, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Euthymics Bioscience, Inc., please visit euthymics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.